These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3684174)

  • 61. Acetylator phenotype in spontaneous SLE and rheumatoid arthritis.
    Lawson DH; Henry DA; Lowe J; Reavey P; Rennie JA; Solomon A
    Ann Rheum Dis; 1979 Apr; 38(2):171-3. PubMed ID: 443884
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acetylation phenotype in hypertensive patients.
    Huang CY; Chu JY; Yen TC
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Jan; 8(1):1-5. PubMed ID: 1548734
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inheritance of liver N-acetyltransferase activity in the rapid and slow acetylator inbred hamster.
    Hein DW; Kirlin WG; Ferguson RJ; Weber WW
    J Pharmacol Exp Ther; 1985 Jun; 233(3):584-7. PubMed ID: 3874278
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Acetylator status of kwashiorkor children in Ibadan (south-west Nigeria).
    Jeyakumar LH; Arowoshegbe UA; Akinyinka OO; Akinbami FO; Bababunmi EA
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):57-62. PubMed ID: 2384118
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relationship of sulfamethazine disposition kinetics to acetylator phenotype in man. A preliminary study.
    Chapron CJ; Blum MR
    J Clin Pharmacol; 1976 Jul; 16(7):338-44. PubMed ID: 947966
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Polymorphic acetylation of sulfamethazine in a Nigerian (Yoruba) population.
    Jeyakumar LH; French MR
    Xenobiotica; 1981 May; 11(5):319-21. PubMed ID: 7293222
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.
    Taja-Chayeb L; González-Fierro A; Miguez-Muñoz C; Trejo-Becerril C; Cruz-Hernandez Ede L; Cantu D; Agundez JA; Vidal-Millan S; Gutierrez O; Dueñas-González A
    Pharmacogenet Genomics; 2011 Dec; 21(12):894-901. PubMed ID: 21946899
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Determination of the acetylator phenotype in a Northern Nigerian population.
    Fawcett IW; Gammon PT
    Tubercle; 1975 Sep; 56(3):199-201. PubMed ID: 1216338
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Influence of double genetic polymorphism on response to sulfamethazine.
    Woolhouse NM; Atu-Taylor LC
    Clin Pharmacol Ther; 1982 Mar; 31(3):377-83. PubMed ID: 7060320
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ecogenetic studies of drug acetylation in man and rats.
    Dubbels R; Khoory R; Schloot W
    Acta Anthropogenet; 1981; 5(2):111-8. PubMed ID: 7271997
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Relationship between the genetically determined acetylator phenotype and DNA damage induced by hydralazine and 2-aminofluorene in cultured rabbit hepatocytes.
    McQueen CA; Maslansky CJ; Glowinski IB; Crescenzi SB; Weber WW; Williams GM
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1269-72. PubMed ID: 6951172
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Caffeine as a potential indicator for acetylator status.
    Rankin RB; Hudson SA; Fell AF
    J Clin Pharm Ther; 1987 Feb; 12(1):47-51. PubMed ID: 3449563
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acetylator phenotype in diabetic neuropathy.
    McLaren EH; Burden AC; Moorhead PJ
    Br Med J; 1977 Jul; 2(6082):291-3. PubMed ID: 871863
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

  • 75. N-acetylation in healthy and diseased children.
    Hadasová E; Brysová V; Kadlcáková E
    Eur J Clin Pharmacol; 1990; 39(1):43-7. PubMed ID: 2276387
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Acetylation phenotype is not associated with breast cancer.
    Ilett KF; Detchon P; Ingram DM; Castleden WM
    Cancer Res; 1990 Oct; 50(20):6649-51. PubMed ID: 2208127
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
    Ylitalo P; Auterinen L; Marttinen A; Koivula T
    Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
    [TBL] [Abstract][Full Text] [Related]  

  • 78. N-acetylator phenotypes in hyperthyroidism.
    Siegmund W; Franke G; Meng S; Gothe P; Meng W
    Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):397-9. PubMed ID: 3220615
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ethanol-induced increase in drug acetylation in man and isolated rat liver cells.
    Olsen H; Mørland J
    Br Med J; 1978 Nov; 2(6147):1260-2. PubMed ID: 709306
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population.
    Ozbek YK; Oztürk T; Tüzüner BM; Calay Z; Ilvan S; Seyhan FM; Kisakesen HI; Oztürk O; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2885-9. PubMed ID: 20683028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.